BioMarin Hints Probable Delay For US Approval For Roctavian, But Analyst Convinced For Transformative 2023
Biomarin Pharmaceutical Inc (NASDAQ:BMRN) reported a break-even in Q4 FY22 compared to a loss of $(0.32) a year ago and the…
Builders FirstSource Sees FY23 Capital Expenditures $300M-$350M
Q1 2023 Total Company Guidance
The Company expects challenging conditions in housing amid elevated mortgage rates and general uncertainty in economic conditions that may significantly impact the business. As a
Ecovyst FY23 Revenue Outlook $760M – $790M Vs. $842.97M Estimate, Adj. EBITDA $285M – $300M
2023 Financial Outlook
Full year 2023 guidance is as follows:
Sales of $760 million to $790 million1
Sales of $145 million to $155 million for
Frontline Registers Over 148% Operating Revenue Growth In Q4 Backed By Recovery In Chinese Demand
Frontline Plc (NYSE:FRO) reported a fourth-quarter operating revenue increase of 148.3% year-over-year to $530.1 million, beating the consensus of $365…
CareDx Sees FY23 Revenue $328M-$338M Vs $338.42M Est
2023 Guidance
For the full year 2023, CareDx expects revenue to be in the range of $328 million to $338 million.
Barings Corporate Investors Reports Preliminary Q4 2022 Results; Net Asset Value Per Share As Of December 31, 2022, Was $16.37, As Compared To $16.59 As Of September 30, 2022
The Board of Trustees of Barings Corporate Investors (NYSE:MCI) (the "Trust") met on February 27, 2023 and would like to report its preliminary financial results for the fourth quarter of
Barings Participation Investors Reports Preliminary Q4 2022 Results; Net Asset Value Per Share As Of December 31, 2022, Was $14.99, As Compared To $15.15 As Of September 30, 2022
The Board of Trustees of Barings Participation Investors (NYSE:MPV) (the "Trust") met on February 27, 2023 and would like to report its preliminary financial results for the fourth
Fisker’s Q4 Top-Line Jumps Seven-Fold; Forecasts Potentially Positive EBITDA For 2023
Fisker Inc (NYSE:FSR) reported fourth-quarter FY22 sales of $306 thousand versus $41 thousand a year ago. Total operating costs and expenses…
Freshpet’s Q4 Highlights: Earnings Beat, Margin Pressure, Capacity Additions & More
Freshpet Inc (NASDAQ:FRPT) reported fourth-quarter FY22 sales growth of 43.1% year-on-year, to $165.83 million, beating the consensus of $152.11 million. The…
FuboTV Stock Is Trading Down Today: What’s Going On?
FuboTV Inc (NYSE: FUBO) shares are plunging Monday morning after the company reported better-than-expected financial results.